Abeona Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAbeona Therapeutics

Abeona Therapeutics(ABEO)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Prademagene zamikeracel

epidermolysis bullosa

,

epidermolysis bullosa dystrophica

fallopian tube neoplasms

,

ovarian epithelial carcinoma

Fluoroquinolone

chronic obstructive pulmonary disease

,

respiratory aspiration

,

healthy volunteers/patients

,

coronary artery disease

,

electrocardiography

,

overactive urinary bladder

,

,

,

,

multiple endocrine neoplasia type 1

,

cystic fibrosis

,

,

,

communicable diseases

,

intraabdominal infections

,

,

,

,

abdominal abscess

,

pelvic infection

,

pelvic inflammatory disease

,

,

wound infection

,

,

aspiration pneumonia

,

,

,

,

respiratory tract infections

,

,

acute cholecystitis

,

healthcare-associated pneumonia

,

bacterial pneumonia

,

neurologic manifestations

,

,

acquired joint deformities

,

,

hematologic diseases

,

febrile neutropenia

,

,

,

,

,

chronic bronchitis

,

,

urinary tract infections

,

,

,

community-acquired pneumonia

,

bacterial infections

,

,

pseudomonas infections

,

,

pyogenic liver abscess

,

maxillary sinusitis

,

,

,

,

disease progression

,

,

,

wounds and injuries

,

chemical and drug induced liver injury

,

,

bacterial skin diseases

,

bronchial diseases

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use